Skip to content

Postoperative Active Recovery

Evaluating a Novel Active Recovery Program in the Immediate Postoperative Period Following Pelvic Reconstructive Surgery: A Randomized Control Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05950633
Enrollment
72
Registered
2023-07-18
Start date
2023-09-01
Completion date
2025-07-31
Last updated
2025-08-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pelvic Floor Disorders

Brief summary

This is a study evaluating a novel active recovery program in the immediate postoperative period following pelvic reconstructive surgery.

Detailed description

This is a randomized controlled trial comparing usual care postoperative restrictions and a novel new active recovery program to look at differences in pelvic floor function, patient quality of life, and mental health in between groups.

Interventions

OTHERStandard of Care

Participants will receive standard of care postoperative instructions

Participants will receive instructions to increase their fitness to walking at least 30 minutes a day for 5 days a week following surgery and abdominal and pelvic floor exercises will focus on abdominal wall strengthening and abdominal pressure management, urinary urgency and retention, bowel and constipation management

Sponsors

Oregon Health and Science University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 89 Years
Healthy volunteers
No

Inclusion criteria

1. Between the ages of 18 and 89 2. Undergoing minimally invasive apical prolapse reconstructive procedure at OHSU. This includes laparoscopic and robotic-assisted sacrocolpopexy, laparoscopic and vaginal uterosacral ligament suspension, and vaginal sacrospinous ligament fixation. We will include patients undergoing concomitant procedures such as hysterectomy and incontinence procedures. 3. Have access to reliable email for communication and questionnaires.

Exclusion criteria

1. Unable to consent 2. Unable to read and complete questionnaires in English 3. Unable to sustain 30 minutes of moderate walking/activity at baseline (self-reported) 4. Use a mobility assistance device such as a walker/cane at baseline 5. Balance or stability problems 6. Patients on chronic opioids

Design outcomes

Primary

MeasureTime frameDescription
Change in the Pelvic Floor Distress Inventory-20 (PFDI-20)Baseline to 12 weeks post-surgeryThe change in the Pelvic Floor Distress Inventory-20 (PFDI-20) between arms from baseline to 12 weeks post-surgery. Participants will be asked to rate how much symptoms bother them from 0 (not at all) to 4 (quite a bit)
Change in the Short Form Health Survey (SF-36)Baseline to 12 weeksThe change in the Short Form Health Survey (SF-36) between arms from baseline to 12 weeks post-surgery. Participants will be asked to rate their overall health. Scores can range from 0 to 100
Change in the Patient Health Questionnaire (PHQ-9)Baseline to 12 weeks post-surgeryThe change in the Patient Health Questionnaire (PHQ-9) between arms from baseline to 12 weeks post-surgery. Participants will be asked to rate how frequently problems have bothered them from 0 (not at all) to 4 (nearly every day)
Change in the Patient Global Impression of Improvement (PGI-I)Baseline to 12 weeks post-surgeryThe change in the Patient Global Impressions of Improvement (PGI-I) between arms from baseline to 12 weeks post-surgery. Participants will be asked to rate their symptoms from 1 (very much better) to 7 (very much worse)

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026